Evaluation of hyaluronan and calcifications in stenotic and regurgitant aortic valves

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 1, 2011, Pages 27-32

  Johansson, Bengt ^a   Holmgren, Anders ^a   Hedström, Magnus ^a   Engström Laurent, Anna ^a   Engström, Karl Gunnar ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aortic stenosis; Human; Hyaluronan

Indexed keywords

HYALURONIC ACID;

ADULT; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; ARTICLE; BIOMECHANICS; CALCIFICATION; CLINICAL ARTICLE; EVALUATION; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERSTITIUM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGED; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CALCINOSIS; FEMALE; HUMANS; HYALURONIC ACID; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; STAINING AND LABELING;

EID: 78651083403     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.04.024     Document Type: Article

References (15)

1. Grande-Allen K.J., Osman N., Ballinger M.L., Dadlani H., Marasco S., Little P.J. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease. Cardiovasc Res 2007, 76:19-28.
2. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4:528-539.
3. Gao F., Yang C.X., Mo W., Liu Y.W., He Y.Q. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Invest Med 2008, 31:E106-E116.
4. Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochim Biophys Acta 1979, 578:281-289.
5. Meyer P.J.K. The polysaccharide in the vitreous humor. J Biol Chem 1934, 107:624-629.
6. Laurent T.C., Laurent U.B., Fraser J.R. Functions of hyaluronan. Ann Rheum Dis 1995, 54:429-432.
7. Shi Y., Ramamurthi A., Vesely I. Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum 2002, 38:35-40.
8. Simionescu D.T., Lovekamp J.J., Vyavahare N.R. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 2003, 12:217-225.
9. Evanko S.P., Raines E.W., Ross R., Gold L.I., Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 1998, 152:533-546.
10. Schroeder J.A., Jackson L.F., Lee D.C., Camenisch T.D. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 2003, 81:392-403.
11. Grande-Allen K. Fibrotic vs. myxomatous remodeling of mitral valves. Conf Proc IEEE Eng Med Biol Soc 2004, 5:3737-3740.
12. Gupta V., Barzilla J.E., Mendez J.S., Stephens E.H., Lee E.L., Collard C.D., Laucirica R., Weigel P.H., Grande-Allen K.J. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc Pathol 2009, 18:191-197.
13. Stephens E.H., Chu C.K., Grande-Allen K.J. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve. Acta Biomater 2008, 4:1148-1160.
14. Baig M.M., Daicoff G.R., Ayoub E.M. Comparative studies of the acid mucopolysaccharide composition of rheumatic and normal heart valves in man. Circ Res 1978, 42:271-275.
15. Butcher J.T., Simmons C.A., Warnock J.N. Mechanobiology of the aortic heart valve. J Heart Valve Dis 2008, 17:62-73.